MEN’S HEALTH QUARTERLY
Longevity

NAD+ Benefits for Women: What the Human Evidence Shows

Energy, menopause, skin, fertility: which claims have human trial data behind them, and which do not.

Words by the editors ·

Short answer: the research on NAD+ in women is thin. Trials of NAD+ precursors such as NMN and NR raise blood NAD+ in adults, and one 10-week trial in postmenopausal women with prediabetes found improved muscle insulin sensitivity, but no trial we reviewed shows that NAD+ products improve energy, skin, fertility or menopause symptoms in women.38 Most "benefits for women" lists come from clinics that sell the products.

This page sorts the common claims by what human evidence exists. For the basics, see what NAD+ is, and for the general side-effect picture see NAD+ benefits and side effects.

In brief

  • NMN and NR raise blood NAD+ in adults, and short oral trials report few problems.12
  • One 10-week trial in postmenopausal women with prediabetes found NMN raised muscle insulin sensitivity; the trial was small and its randomization was questioned.34
  • NR did not significantly improve fatigue versus placebo in a long-COVID trial.5
  • We found no randomized trial of NAD+ for menopause symptoms, skin or fertility.
  • The FDA does not approve dietary supplements before they are sold; compounded NAD+ injections are not FDA-approved.67

What are the benefits of NAD+ for women?

NAD+ is a coenzyme that cells use in energy metabolism, DNA repair and stress signaling, and nothing about that biology is specific to women.8 The claims aimed at women are marketing categories: energy, hormone balance, skin, fertility and "healthy aging". The table below sets each against the published human evidence we could verify.

Claim often madeWhat the human evidence shows
Raises NAD+ levelsYes, for oral precursors in adults over weeks. NR raised whole-blood NAD+ in a randomized trial and was well tolerated in healthy middle-aged and older adults.19
Improves metabolism or insulin sensitivityOne 10-week trial in postmenopausal women with prediabetes who were overweight or obese found NMN increased muscle insulin sensitivity. A published comment questioned whether randomization was effective.34
More energyA trial of NR in long-COVID raised NAD+ but did not significantly improve fatigue versus placebo.5
Menopause symptoms, skin, fertilityWe found no randomized human trial of NAD+ products for these in the sources reviewed for this page. Treat these as unproven.
Injections are strongerA 2026 review calls the evidence for intravenous NAD+ preliminary and says long-term safety data are lacking.8

What did the trial in postmenopausal women find?

The most cited women-specific result is a randomized, placebo-controlled, double-blind trial published in Science in 2021. Over 10 weeks, postmenopausal women with prediabetes who were overweight or obese took NMN or placebo. In the NMN group, insulin-stimulated glucose disposal and muscle insulin signaling increased, and they did not change with placebo.3

Three cautions apply. First, it was a small study: a published comment counted 13 women in the NMN group and 12 on placebo, and argued that liver fat differed sharply between the groups at the start (6.3% versus 14.8%), so the trial was not effectively randomized on that measure.4 Second, the women had a specific profile, so the result does not describe healthy women or women in other life stages. Third, the authors declared patent and licensing interests related to NMN.3

Better insulin sensitivity in a lab measurement is also not the same as a woman feeling or functioning differently. The trial reports the first; it does not claim the second.

Is NAD+ safe for women?

For short-term oral use in healthy adults, the trials we read report few problems. In a randomized trial in 31 healthy men and women aged 20 to 65, NMN at 1,250 mg once daily for up to 4 weeks produced no changes beyond normal variation in blood, urine and body-composition tests and no severe adverse events.2 A systematic review of 10 randomized trials with 489 participants found the products well tolerated, with muscle pain, nervous disorders, fatigue, sleep disturbance and headache the most common events.10

These trials were short, mostly funded by or linked to makers of the ingredients, and not designed to answer questions about pregnancy or breastfeeding. We did not find pregnancy or lactation safety data in the sources we reviewed, so the absence of evidence should not be read as safety. The FDA advises people to talk to a doctor, pharmacist or other health professional before using a supplement.6

Are NAD+ injections different for women?

We found no study that tested NAD+ injections in women as a separate group, and none that compared injections with oral precursors. Intravenous NAD+ has been linked to nausea, cramping, flushing and chest discomfort, and the evidence base is mostly small and uncontrolled.8 Compounded NAD+ injections are not FDA-approved, and the FDA says it does not verify the safety, effectiveness or quality of compounded drugs before they are marketed.7

Supplements are regulated differently. Under the law that governs them, the FDA is not authorized to approve dietary supplements for safety and effectiveness before they are marketed, which is one reason labels and ingredient amounts can vary by brand.6 Our look at whether NAD+ supplements are worth it covers the oral trials in more detail, and the evidence on NAD+ injections and energy covers the injection side.

Do women have low NAD+ with age?

A common pitch says NAD+ falls with age and women need to replace it. A 2026 review notes that recent large human datasets show whole-blood NAD+ does not decline with healthy aging on its own.8 Tissue levels may differ from blood, so this is not final, but a higher blood number is not proof of a deficiency being corrected.

How to judge a claim about NAD+ and women

For readers asking about energy and aging more generally, our piece on how the body changes after 40 covers what is established.

Talk to a clinician. This article explains the evidence; it cannot tell you what is right for you. A licensed clinician who knows your health history and medications can.
Important safety information. Supplements can interact with medicines and are not suitable for everyone, including during pregnancy or breastfeeding.11 Heavy or unusual bleeding, bleeding between periods, or symptoms that disrupt daily life should be assessed by a clinician rather than treated with a supplement.12 Only a licensed clinician who knows your health history should decide what is appropriate for you.

Questions

Does NAD+ help with menopause symptoms?

We found no randomized trial testing NAD+ products for menopause symptoms. One small trial in postmenopausal women with prediabetes measured muscle insulin sensitivity, not symptoms.

Is NAD+ safe for women?

Short oral trials in healthy adults, including women, report few problems, but they were brief. Pregnancy and breastfeeding were not addressed in the sources we reviewed, so ask a clinician first.

Do NAD+ injections work better for women?

No study we found tested injections in women separately or compared them with oral forms. A 2026 review calls intravenous NAD+ evidence preliminary.

Can NAD+ improve energy?

Precursors raise blood NAD+, but a long-COVID trial of NR found no significant fatigue benefit versus placebo.

Also in this edition

Part of our guide: Aging Well: NAD+, Exercise and the Male Body After 40

Notes

  1. Conze D, Brenner C, Kruger CL. Safety and metabolism of long-term administration of NIAGEN (nicotinamide riboside chloride) in a randomized, double-blind, placebo-controlled clinical trial of healthy overweight adults. Sci Rep. 2019. PubMed 31278280.
  2. Fukamizu Y, et al. Safety evaluation of β-nicotinamide mononucleotide oral administration in healthy adult men and women. Sci Rep. 2022. PubMed 36002548.
  3. Yoshino M, et al. Nicotinamide mononucleotide increases muscle insulin sensitivity in prediabetic women. Science. 2021. PubMed 33888596.
  4. Brenner C. Comment on "Nicotinamide mononucleotide increases muscle insulin sensitivity in prediabetic women". Science. 2021. PubMed 34326206.
  5. Wu CY, et al. Effects of nicotinamide riboside on NAD+ levels, cognition, and symptom recovery in long-COVID: a randomized controlled trial. EClinicalMedicine. 2025. PubMed 41357333.
  6. U.S. Food and Drug Administration. Information for Consumers on Using Dietary Supplements.
  7. U.S. Food and Drug Administration. Compounding and the FDA: Questions and Answers.
  8. Alangari A, et al. Narrative review of intravenous NAD(+) and NAD(+) precursors in wellness and translational medicine. Front Aging. 2026. PubMed 42787547.
  9. Martens CR, et al. Chronic nicotinamide riboside supplementation is well-tolerated and elevates NAD+ in healthy middle-aged and older adults. Nat Commun. 2018. PubMed 29599478.
  10. Gindri IM, et al. Evaluation of safety and effectiveness of NAD in different clinical conditions: a systematic review. Am J Physiol Endocrinol Metab. 2024. PubMed 37971292.
  11. National Center for Complementary and Integrative Health. Black Cohosh: Usefulness and Safety. NIH.
  12. The North American Menopause Society. The 2023 nonhormone therapy position statement of The North American Menopause Society. Menopause. 2023. PubMed 37252752.